US3864484A - Therapeutic compositions and methods using silymarin comprising poly-hydroxyphenyl chromanones - Google Patents

Abstract

Subjects suffering from liver damage or inflammation or other infirmities susceptible to treatment with Silymarin are treated by administering thereto Silymarin comprising polyhydroxyphenyl chromanones recovered from the dried fruit of Silybum marianum Gaertn. By separating the fatty oils therefrom, extracting the remaining solid residue with ethyl acetate, evaporating the ethyl acetate and dissolving the dry residue in a solvent mixture comprising methanol, water and petroleum ether to form a twophase system wherein the chromanones are contained in the lower phase, recovering the polyhydroxyphenyl chromanones from the lower phase after subjecting same to multiple countercurrent contact with petroleum ether.

Description

United States Patent Madaus [4 1 Feb. 4, 1975 [75] Inventor: Rolf Madaus,Cologne-Merheim,

Germany {73] Assignee: Dr. Madaus & C0., Cologne,

Germany [22] Filed: May 19, 1972 [21] Appl. No: 255,177

I Related Application Data [62] Division of Ser. No. 828,353, May 27, 1972, Pat. No.

[52] US. Cl. 424/195 [51] Int. Cl A6lk 27/14 [58] Field of Search 424/195' [56] References Cited OTHER PUBLICATIONS Hahn et al., Chem. Abst., Vol. 69, (l968), p. 58230r.

Primary Examiner-Sam Rosen Attorney, Agent, or Firm-Burgess, Dinklage & Sprung [57] ABSTRACT Subjects Suffering from liver-damage or inflammation or other infirmities susceptible to treatment with Silymarin are treated by administering thereto Silymarin comprising. polyhydroxyphenyl chromanones recovered from the dried fruit of Silybum marianum Gaerm, by separating the fatty oils therefrom, extracting the remaining solid residue with ethyl acetate, evaporating the ethyl acetate and dissolving the dry residue in a solvent mixture comprising methanol, water and petroleum ether to form a two-phase system wherein the chromanones are contained in the lower phase. recovering the polyhydroxyphenyl chromanones from the lower phase after subjecting same to multiple countercurrent contact with petroleum ether.

7 Claims, N0 Drawings THERAPEUTIC COMPOSITIONS AND METHODS USING SILYMARIN COMPRISING POLY-.HYDROXYPI-IENYL CHROMANONES This application is a division of parent application Ser. No. 828,353, issued to US. Pat. No. 3,773,932.

This invention relates to a novel and improved process for recovering polyhydroxyphenyl chromones. More particularly this invention relates to a method for recovering polyhydroxyphenyl chromones having valuable pharmacological properties.

It has been found that certain polyhydroxyphenyl chromones for example silymaun have a detoxifying and protection effect against various toxicants in the body.

The known methods of isolating polyhydroxyphenyl chromones and which have been used heretofore in the laboratory have not been found suitable for application on a large scale. This is because the starting material, i.e., the fruit of Silybum marianum Gaertn. contains up to 30 percent of fatty oils and other additional but difficultly removable by-products so that only greasy concentrates are obtained which can be further processed only with extreme difficulty. Adapting the known methods to large scale operation has furthermore not proved practical because of the extremely long times needed for the processing and because ofthe many solvents which are required to be introduced individually and repeatedly oneafter the other in sequence in order to effect the removal of the non-active by-products and fatty oils.

All the methods known to-date for removing fatty substances such as are herein involved. utilizing conventional extraction procedures take at least 7 days to carry out and even then inmost cases have not proved satisfactory. r

In accordance with the invention, it has now been found that it is not necessary to effect a complete defatting, and that a starting material containing at least from to percent of fatty oils can be satisfactorily used. Such starting materials-can be relatively easily and economically obtained by subjecting dried silybum marianum fruit to defatting by application of high pressure thereto, preferably with a screw press such as is conventionally used for treating other oil seeds. Under such treatment to percent of the fatty oil can be removed without any loss of active material.

When this defatting method is employed the otherwise additional grinding heretofore required is not necessary as the cell walls or membranes are forcedopen by the high pressure and by the grinding action of the screw press to such an extent that the active substance quickly and completely passes into the extraction agent.

However, because of the remaining content of fatty oil an extraction agent must be utilized in which the fatty oils as well as the active substance are readily soluble. In accordance with the invention it has been found that the most suitable solvent for this purpose is ethyl acetate. Ethyl acetate allows for an exhaustive extraction to be carried out in 24hours or less while the conventional extraction with acetone requires an extraction time of 14 days or more.

Following the evaporation of the ethyl acetate an oily greasy partially lumpy product is obtained containing approximately 20 to percent of active substance. In order to avoid repeated treatment with different solvents and in order to obtain a separation of the active substances from the by-products and fatty oils under economically feasible conditions in accordance with the invention a distributing method involving two substantially immiscible liquid phases have been proposed.

The selection ofa suitable solvent system for this purpose was not successful prior to the invention because all of the tested phase pairs from the distribution value G of the mixture of the by-products and the fatty oil and of the distribution value G of the active materials resulted in such low separation factors B that the value of the requireddistribution stages necessitated an unbearable expenditure for equipment and labor.

For the phase pair methanol/petroleum ether wherein the petroleum ether has a boiling point of from 40 to 60C there was calculated from the distribution values G 0.25 and G 0.038 obtained for an active material concentration of 2 percent the separation factor being at 6.5 which would have required theoretically for a 70-80% enrichment about 20 distribution stages. However, in actual operation a very strong phase shifting within the system takes place during the distribution and all attempts to lessen the same by addition of water proved successful.

In accordance with the invention, there was found that the ternary system methanol/water/petroleum ether avoids the disadvantages associated with the methanol/petroleum ether system. The most favorable methanol/water/petroleum ether mixture has been found to be methanol/water (9515) as lower phase in equilibrium with purepetroleum ether wherein the petroleum ether has a boiling point of from 40 to 60C. The system in equilibrium furthermore had the advantage of an unexpected shifting of the distribution values in favor of the desired purification process for theactive substances.

The applicants invention therefore lies in a method for recovering polyhydroxyphenyl chromones which comprises subjecting the dried fruits of Silybum marianum Gaertn. to high mechanical pressure, for example in a screw press, whereby the cell walls are ruptured and freed of the major amount of fatty oils contained therein, exhaustively extracting the remaining solid residue from the press which still contains oil in an amount of 5 to 10 percent with ethyl acetate, evaporating the ethyl'acetate, dissolving the oil-greasy, partially lumpy dry residue thereby obtained and which contains about 20 to 30 percent of active material to form a concentration thereof of 2 wt percent in the lower phase of a solvent system consisting of, for example, methanol water and petroleum ether in order to separate therefrom the undesirable by-products,-centrifuging the solvent system for removal therefrom of flaky solid material constituting impurities and undesirable by-products, thereafter subjecting the solvent system to a multiplication, preferably uniform distribution by counter-current contact of the upper and lower phases, and recovering from the lower phase by concentration in vacuo a brownish powder containing to percent of polyhydroxyphenyl chromones.

In practical operation of the system in accordance with the invention, it was surprisingly found that a stage value n 6 suffices in order to obtain a 70-80 percent enrichment of the active material.

In the multiplicative distribution which may be carried out in stages or uniformly and is preferably conducted in a counter current procedure, the lower phase becomes enriched in active material and may be recovered with the lower phase at the discharge end of the apparatus.

As apparatus, there are required for the uniform multiplicative distribution 6 individual stages with for instance each having one centrifugal separator and one emulsifier which are so arranged in sequence that the purified active material continuously runs off with the heavy or lower phase, the upper or lighter phase which is flowed counter current to the lower, or heavier phase runs off at the opposite end of the battery after passing through the 6 emulsifiers and separator stages.v

A comparable degree of efficiency is obtained using a column device as described by Zi'ehl, in which case a theoretical bottom value of IO to 12 is to be used (calculated from HTU height for one transfer unit).

In both methods of operation, it has proved advantageous to make an addition of material at the beginning of the battery as described by Jantzen as well as in the middle according to van Dyk. The addition is supplied in the form of a 2 percent solution in the lower phase.

Following the distribution carried out in accordance with the invention there is recovered the purified active materials in the for m of a beige-colored dry product by the evaporation of the lower phase; The dry product contains 70-80 percent silymarin and may be used in this form directly or it may first be subjected to further purification and/or separation procedures.

In a thin-layer chromatographic separation of the resulting silymarin, there may be obtained on polyamide plates using as the separation agent a mixture of chloroform: methanol: methylethylketone (60:14:26) and a l percent dinitrophenylhydrazine solution, 4 distinctly separated materials I, II, III and IV. I

The material having the largest R -v'alue Silymarin I was established as to its basic structure. It has the empirical formula C H O and is a 5,7-dihydroxy-2-(3- methoxy-4'-hydroxyphenyl)-chrornanone-3-ol which is substituted in the 7-position with a C H O -radical. It has a melting point of 167C.

The remaining three materials II, III and IV have not as yet had their exact structure determined, but they can be separated by column chromatography and by crystallization. All of them show, as silymarin I, the same effects in pharmacological tests.

Thus it is justified due to the considerable evidence of pharmacological conformity to maintain the designation Silymarin for the product of the process of the invention which consists of a mixtureof-the materials I, II, III and IV and to designate the individual c'omponents as Silymarin I, Silymarin II, Silymarin III and Silymarin IV.

Silymarin I can be directly separated from the lower phase running off the distributionapparatus by crystallization. For this purpose, the lower phase after treatment with active charcoal is at first only-compressed to such an extent that after the removal ofthe active charcoal on further compressing, Silymarin I is separated in crystalline form.

Thus in accordance with the invention, the recovery of polyhydroxyphenyl chromones, and particularly of silymarin and/or its components as set out above, comprises in accordance with the invention the following steps:

l. Pressing off from the Silybum marianum fruit the main amount of the fatty oils under high pressure, preferably in a screw press;

2. Exhaustive extraction of the oil press residue which remains and which still contains some fatty oils with ethyl acetate, evaporation of the solvent and recovery of an oily-greasy primary extract;

3. Uniform multiplicativedistribution of the primary extract in the solvent system according to the invention and the recovery of a dry product having a content of 70 to 80 percent of silymarin; and

4. If desired, prior separation of silymarin I by crystalliZation from the lower or heavier phase and the recovery of the other polyhydroxyphenyl chromones from the remaining mother liquor.

The following Exampleis given to illustrate the present invention, however, is in nowise to be construed as a limitation thereof.

EXAMPLE l. I kg of the dried fruits of Silybum marianum were freed from the main amount of fatty oils containedtherein using a screw press as conventionally used for oil seeds under high pressure of from 250 to 280 kg/cm There were thereby obtained approximately 75 to 80 kg of press residue having an oil content of to percent. 2. 80 kg of this press residue were exhaustively extracted with ethyl acetate. The residue was thereby substantiallyfreed from polyhydroxy phenol chromones and from the residual oil; 80 kilocomprising methanol/water (95:5parts by volume)/petroleum ether, wherein the petroleum ether has a boiling point of from 40 to 60C and centrifuged off from flaky solid substances. The final volume amounted to about 300 liters of lower phase.-

Six individual centrifugal separators adapted for liquid/liquid-separation were arranged in series with one emulsifying stage, inserted between each two centrifugers, so that in operation the lower or heavier phase passed through the upper phase in counter flow and wherein in each instance in the emulsifying stage.

both phases were emulsified one into the other so as to effect exchange of the active material. In each following separator stage, the emulsion was again separated into heavy and light phases. The conduits or lines were so arranged that the separated upper phase which was being flowed in counter current to the lower phase passed into eachpreceding emulsifying stage, etc.

The upper and lower phases were first passed continuously against one another in the distribution battery containing no active substances, i.e., without loading, so that the phase equilibrium was established. A 2 percent solution of active material was then fed continuously into the flowing lower phase. On introducing the solution of active material at the inlet of the lower phase, it must be kept ,in mind that the total flowing volumeratio, i.e., upper phase: lower phase l:l must not be changed.

The flow velocity of both phases depends extensively on the degree of efficiency of the emulsifying units and on the separators. The optimum regulation can be ascertained gravimetrically by quantitative determinations of thetransition values of the active material.

The lower phase (about 300 l) discharged from the distribution battery was dried in 'vacuo at 20 mm Hg and resulted in a beige-colored to brownish powder in a weight yield of 3.1 kg. The content of active material (Silymarin) amounted to between 70 and 80 percent. with a yield of active material of 2.2 percent. calculated on the starting material.

4, Modificationfor the direct recovery of Silymarin I from the lower phase:

The lower phase (about 300 l) leaving the distribution battery was collected, treated with 1.5 kg of active charcoal and compressed to 1001 in vacuum at 20 mm Hg. The solution while still hot was purified on a filter press and afterwards further compressed. In the range of about 50 to 30'l remaining volume, an increasing crystallization is initiated. Depending on the degree of concentration, a white to ochre-colored crystallization was obtained. I

The crystallizate had a melting point of 167 to 169C. It consisted of Silymarin l and had a degree of purity of 95'to 100 percent.

The mother liquor remaining after separating out the crystallizate, which mother liquor still contain Silymarin II, III and IV, was dried by further compressing in vacuum at 20 mm Hg.

The polyhydroxyphenyl chromones obtained according to the method of theinvention demonstratedin experimental tests carried out on animals a marked protective effectagainst liver-damaging influences of various toxicants.

The degree of liver damage, for instance produced with carbon tetrachloride, can be determined for example by the hexobarbital period of sleep. Inasmuch as damaged liver cells cannot rapidly catabolize the hexobarbital, the period of sleep is very appreciably prolonged in the case of liver damage. When Silymarin was administered previous to the hexobarbital, there resulted a shortening of this period of sleep-prolongation by 59.2 percent, i.e., an antagonization of the effect of the carbon tetrachloride by the Silymarin.

A liver damaged by carbon tetrachloride furthermore is able to catabolize p-oxyphenyl pyroracemic acid only to a diminished extent, which for this reason therefore appears in increased amounts in the urine. Untreated rats excreted within four hours percent of the amounts of p-oxyphenyl pyroracemic acid given, while rats damaged by carbon tetrachloride excreted percent. If, however, they had previously received Silymarin, the excretion time normalized at 8-l0%. The animals behaved as if there had not been any liver damage by the carbon tetrachloride.

When the allyl alcohol test according to EGER was carried out, Silymarin caused a lessening of the necrosis area by almost half.

In experiments with a-amanitine (poisoning with a fungus of the genus amanita), the protective effect of the Silymarin was demonstrated by the lessening of the death rate or lengthening of the survival time, by the slower weight decrease, and the more rapid commencement ofa weight increase and finally by the distinctive antagonization of the increase of the concentration of the sorbitol dehydrogenase.

The cirrhotic liver damage resulting from administration of thioacetamide over a long period of time'could also be counter-acted by the simultaneous administration of Silymarin. Depending on the Silymarin dosage, a considerable inhibition of the body weight loss and an appreciable prolongation of the survival time were obtained. V

This effect of the Silymarin in protecting the cell structure and the, cytometabolism was also confirmed in numerous further experiments. Even damage which had already occurred could be reversed by administering Silymarin. It was established by electronmicroscopic examination that the structure ofthe mitochondria and of the endoplasmatic reticulum considerably destroyed after administering a-amanitine could be fully restored again by Silymarin. The restoration of the disturbed integrity means that Silymarin does not only have a protective but also a stabilizing effect.

Thus, the immediate effect on the structural elements of the liver cell provides for a completely novel form of therapy. j

Over 600 evaluated cases of chronic hepatitis, posthepatitic conditions, lever cirrhosis showed, after an average of 5 weeks of daily administration of 0.2 g Silymarin a regression exceeding percent The most important liver function tests showed, in comparison to a control group treated in the usual manner, on the average a regression twice as large as that'observed in the controls. In fatty livers, the bioptic findings showed after Silymarin treatment, a cure rate of,67 percent of the cases, in the control group only in 40 percent of the cases.

All cases showed after administration of Silymarin for only a short period of time, an improvement of the general state of health, lessening ofthe meteorism and of the tension feeling in the right upper abdomen, in- Y crease of appetite. increase in body weight and of efficiency. Side-effects were also not observed attributable to the Silymarin after prolonged periods of treatment.

Tablets, sugar coated tablets or capsules are used for oral therapy, each one containing 35 mg Silymarin imbedded in indifferent carriers.

The regime starts with 3 times daily 2 tablets for a period of 4 to 6 weeks followed by a maintenance dose of 3 times 1 tablet daily,

Until now clinical experience is available with 600 patientsThey consist of post-hepatitic cases, chronic hepatitides, liver cirrhoses, fatty liver and liver damage dueto the application ofliver damaging substances (alcohol).

I claim:

l. A method for treating subjects for hepatitis, cirrhosis or chemical-induced liver damage, which comprises administering to such a subject a therapeutically.

effective amount of a Silymarin composition comprising polyhydroxyphenyl chromanones obtained by a process which comprises the steps of l subjecting the dried fruits of Silybum marianum Garm. to high mecentrifuging said solvent mixture to remove any solid material present therein and separating the upper and lower phases, (6) thereafter subjecting the liquid portion comprising the lower phase to multiple countercurrent contact with petroleum ether, whereby a thorough mixing and separation of both phases occurs, and (7) recovering the polyhydroxyphenyl chromanones from the lower phase by evaporation of the solvent to dryness.

2. Method for protecting a subject against chemicalinduced liver damage by administering thereto a therapeutically effective amount ofa composition according to claim 1. 4

3. Method as claimed in claim 1 wherein the residue obtained in step (2) after extraction with ethyl acetate contains from about to 30 percent of Silymarin comprising polyhydroxyphenyl chromanones.

4. Method as claimed in claim 1 wherein the multiple counter current contact is carried out in a distribution battery consisting of at least six centrifugal separators and at least six emulsifiers arranged in sequence, and wherein the methanol phase is introduced at one end of the battery and petroleum ether is introduced at the opposite end of the battery.

5. Method as claimed in claim 1 wherein the upper phase is separated and each of said centrifugal separators is passed into the next preceding emulsifier for mixing therein with the lower phase.

6. Method as claimed in claim 1 wherein the volume ratio between the said lower phase and the said upper phase in step (6) is about 1:1.

7. Therapeutic composition for treatment of liver inflammation comprising, in a dosage unit form, an effective amount of a Silymarin composition comprising polyhydroxyphenyl chromenones obtained by a process which comprises the steps of ('1) subjecting the dried fruits of Silymarin marianum Garm. to high mechanical pressure whereby the cell walls of the fruits are ruptured and the major amount of fatty oils contained in the fruits is separated therefrom, (2) exhaustively extracting the remaining solid residue which still contains fatty oils in an amount of about 5 to l() percent with ethyl acetate, (3) evaporating the ethyl acetate, (4) dissolving the oil-greasy, partially lum'py dry residue thereby obtained in a solvent mixture comprising methanol, .water andpetroleum ether whereby an upper phase and a lower phase are formed and wherein said chromanones are contained in the lower phase. (5) centrifuging said solvent mixture to remove any solid material present therein and separating the upper and lower phases, (6) thereafter subjecting the liquid portion comprising the lower phase to multiple countercurrent contact with petroleum ether, whereby a thorough mixing and separation of both phases occurs, and (7) recovering the polyhydroxyphenyl chromanones from the lower phase by evaporation of the solvent to dryness.

UNITED STATES PATENT OFFICE CERTIFICATE OF CORRECTION Inventor (s) It is certified thatverror appears in the above-identified patent and that said Letters Patent are hereby corrected as shown below:

On the Title page in item [621 first line,

"Division of Ser. No. 828,555 May 27, 1972" should read Division of Ser. No. 828,353 May 27, 1969 second line,

"Pat. NO. 3,777,952" should read Pat. No. 3,773,932

Please insert also on 30 Foreign Application Title P the following Priority a June 1 1968 Germany.

Column 1, line 12 delete "silymaun" and insert therefor --silymarin--.

Column 1, line 13 delete "protection" and insert therefor -protective--.

Column 5, line 20 delete "crystallization" and nsert therefor "CIYStaHizam".

Signed and. sealed this 13th day of May 1975.

(SEAL)- Attest:

C. MARSHALL DANN RUTH C. MASON Commissioner of Patents Attesting Officer and Trademarks FORM PO-IOSO (10-69) USCOMM-DC ooa7o-po9 U.S GOVIRIJHINT PRINTING OFFICE: 869- 93 o

Claims (7)

1. A METHOD FOR TREATING SUBJECTS FOR HEPATITIS, CIRRHOSIS OR CHEMICAL-INDUCED LIVER DAMAGE, WHICH COMPRISES ADMINISTERING TO SUCH A SUBJECT A THERAPEUTICALLY EFFECTIVE AMOUNT OF A SILYMARIN COMPOSITION COMPRISING POLYHYDROXYPHENYL CHROMANONES OBTAINED BY A PROCESS WHICH COMPRISES THE STEPS OF (1) SUBJECTING THE DRIED FRUITS OF SILYBUM MARIANUM GARTN. TO HIGH MECHANICAL PRESSURE WHEREBY THE CELL WALLS OF THE FRUITS ARE RUPTURED AND THE MAJOR AMOUNT OF FATTY OILS CONTAINED IN THE FRUITS IS SEPARATED THEREFROM, (2) EXHAUSTIVELY EXTRACTING THE REMAINING SOLID RESIDUE WHICH STILL CONTAINS FATTY OILS IN AN AMOUNT OF ABOUT 5 TO 10 PERCENT WITH ETHYL ACETATE, (3) EVAPORATING THE ETHYL ACETATE, (4) DISSOLVING THE OIL-GREASY, PARTIALLY LUMPY DRY RESIDUE THEREBY OBTAINED IN A SOLVENT, MIXTURE COMPRISING METHANOL, WATER AND PETROLEUM ETHER WHEREBY AN UPPER PHASE AND A LOWER PHASE ARE FORMED AND WHEREIN SAID CHROMANONES ARE CONTAINED IN THE LOWER PHASE, (5) CENTRIFUGING SAID SOLVENT MIXTURE TO REMOVE ANY SOLID MATERIAL PRESENT THEREIN AND SEPARATING THE UPPER AND LOWER PHASES, (6) THEREAFTER SUBJECTING THE LIQUID PORTION COMPRISING THE LOWER PHASE TO MULTIPLE COUNTER-CURRENT CONTACT WITH PETROLEUM ETHER, WHEREBY A THOROUGH MIXING AND SEPARATION OF BOTH PHASES OCCURS, AND (7) RECOVERING THE POLYHYDROXYPHENYL CHROMANONES FROM THE LOWER PHASE BY EVAPORATIN OF THE SOLVENT TO DRYNESS.

2. Method for protecting a subject against chemical-induced liver damage by administering thereto a therapeutically effective amount of a composition according to claim 1.

3. Method as claimed in claim 1 wherein the residue obtained in step (2) after extraction with ethyl acetate contains from about 20 to 30 percent of Silymarin comprising polyhydroxyphenyl chromanones.

4. Method as claimed in claim 1 wherein the multiple counter current contact is carried out in a distribution battery consisting of at least six centrifugal separators and at least six emulsifiers arranged in sequence, and wherein the methanol phase is introduced at one end of the battery and petroleum ether is introduced at the opposite end of the battery.

5. Method as claimed in claim 1 wherein the upper phase is separated and each of said centrifugal separators is passed into the next preceding emulsifier for mixing therein with the lower phase.

6. Method as claimed in claim 1 wherein the volume ratio between the said lower phase and the said upper phase in step (6) is about 1:1.

7. Therapeutic composition for treatment of liver inflammation comprising, in a dosage unit form, an effective amount of a Silymarin composition comprising polyhydroxyphenyl chromenones obtained by a process which comprises the steps of (1) subjecting the dried fruits of Silymarin marianum Gartn. to high mechanical pressure whereby the cell walls of the fruits are ruptured and the major amount of fatty oils contained in the fruits is separated therefrom, (2) exhaustively extracting the remaining solid residue which still contains fatty oils in an amount of about 5 to 10 percent with ethyl acetate, (3) evaporating the ethyl acetate, (4) dissolving the oil-greasy, partially lumpy dry residue thereby obtained in a solvent mixture comprising methanol, water and petroleum ether whereby an upper phase and a lower phase are formed and wherein said chromanones are contained in the lower phase, (5) centrifuging said solvent mixture to remove any solid material present therein and separating the upper and lower phases, (6) thereafter subjecting the liquid portion comprising the lower phase to multiple counter-current contact with petroleum ether, whereby a thorough mixing and separation of both phases occurs, and (7) recovering the polyhydroxyphenyl chromanones from the lower phase by evaporation of the solvent to dryness.